Careers  |  Sign In  |  Register  |   Twitter

A Farewell to Needles: FDA Approves New Inhalable Insulin Product

For the 25 million American adults with diabetes, a new way to control blood sugar levels at mealtimes is right around the corner, an article published by CBS News reports. The FDA approved MannKind Corp.’s Afrezza, a fast-acting insulin product which comes in the form of a powder-filled cartridge. The drug can help patients reach peak insulin levels in as little as 12 minutes, compared to current wait of an hour and a half or more required with injectable insulin.

Read the article published by Reuters.